@ubali1.bsky.social
AI-Native Biotech Is an Opportunity for UK Leadership and Growth via @InstituteGC institute.global/insights/pub...
AI-Native Biotech Is an Opportunity for UK Leadership and Growth
AI-Native Biotech Is an Opportunity for UK Leadership and Growth
institute.global
November 20, 2025 at 10:30 AM
AI-Native Biotech Is an Opportunity for UK Leadership and Growth via @InstituteGC institute.global/insights/pub...
Nxera lays off 15% of staff, pivots pipeline focus in profitability push www.fiercebiotech.com/biotech/nxer...
Nxera lays off 15% of staff, pivots pipeline focus in profitability push
Nxera Pharma plans to lay off | Nxera Pharma has outlined plans to lay off 15% of its staff and prioritize its pipeline as part of a push to clear its path to profitability.
www.fiercebiotech.com
November 18, 2025 at 10:55 AM
Nxera lays off 15% of staff, pivots pipeline focus in profitability push www.fiercebiotech.com/biotech/nxer...
Nice perspective on the necessity of creating an ecosystem of innovation in the life sciences...
Bell Labs Wasn't Built in a Day. Or Two Years. omicsomics.blogspot.com/2025/11/bell...
Bell Labs Wasn't Built in a Day. Or Two Years. omicsomics.blogspot.com/2025/11/bell...
Bell Labs Wasn't Built in a Day. Or Two Years.
Rome is famous for persisting for centuries - and having not been built in a day. If you go there, then one of the most magnificent sites is...
omicsomics.blogspot.com
November 18, 2025 at 10:54 AM
Nice perspective on the necessity of creating an ecosystem of innovation in the life sciences...
Bell Labs Wasn't Built in a Day. Or Two Years. omicsomics.blogspot.com/2025/11/bell...
Bell Labs Wasn't Built in a Day. Or Two Years. omicsomics.blogspot.com/2025/11/bell...
Reposted
'The Evidence' on the BBC World Service where we discussed weight loss medications, which we recorded at the Wellcome Collection a couple of weeks ago #obesityisnotachoice www.bbc.com/audio/play/p...
BBC Audio | The Explanation | Weight loss jabs: A medical game changer?
Do weight loss injections have far-reaching benefits beyond weight management?
www.bbc.com
October 19, 2025 at 1:25 PM
'The Evidence' on the BBC World Service where we discussed weight loss medications, which we recorded at the Wellcome Collection a couple of weeks ago #obesityisnotachoice www.bbc.com/audio/play/p...
Reposted
Dozens of clinical trials are underway trying to change the landscape of autoimmune disease therapy:
Autoimmune Disease, Transformed?
www.science.org
May 20, 2025 at 8:15 PM
Dozens of clinical trials are underway trying to change the landscape of autoimmune disease therapy:
Is there a renaissance in GPCR drug development? www.nature.com/articles/d42...
Is there a renaissance in GPCR drug development?
Sitting at the top of many human signalling cascades, G-protein coupled receptors (GPCRs) play crucial roles in mood, sleep, appetite and every heartbeat. Historically challenging to develop, selectiv...
www.nature.com
January 8, 2025 at 12:01 AM
Is there a renaissance in GPCR drug development? www.nature.com/articles/d42...
Reposted
Questions about the GLP-1 agonist class that we might start resolving this year:
Another GLP-1 Year
www.science.org
January 6, 2025 at 8:01 PM
Questions about the GLP-1 agonist class that we might start resolving this year:
Reposted
Probability isn’t a property of the world but a tool to navigate uncertainty conceived from subjective judgments and assumptions. #AcademicSky #NurseSky #PhilSky
All of statistics and much of science depends on probability — an astonishing achievement, considering no one’s really sure what it is. 🧪
www.nature.com/articles/d41...
www.nature.com/articles/d41...
Why probability probably doesn’t exist (but it is useful to act like it does)
All of statistics and much of science depends on probability — an astonishing achievement, considering no one’s really sure what it is.
www.nature.com
December 20, 2024 at 6:08 AM
Probability isn’t a property of the world but a tool to navigate uncertainty conceived from subjective judgments and assumptions. #AcademicSky #NurseSky #PhilSky
Reposted
Neuroscience students asked us to teach a PRACTICAL course on experimental methods, and it is now on YouTube!
Please like and repost to help us get the word out!
www.youtube.com/playlist?lis...
Lecture 1: Signals and data acquisition
Focusing on hardware, digital/analog I/O, synchronization
🧵
Please like and repost to help us get the word out!
www.youtube.com/playlist?lis...
Lecture 1: Signals and data acquisition
Focusing on hardware, digital/analog I/O, synchronization
🧵
Neuroscience methods - YouTube
Nanocourse: Approaches to Study Neural Circuits This course was taught by Anita Autry, Tiago Gonçalves, and Luke Sjulson at Albert Einstein College of Medici...
www.youtube.com
December 13, 2024 at 11:33 AM
Neuroscience students asked us to teach a PRACTICAL course on experimental methods, and it is now on YouTube!
Please like and repost to help us get the word out!
www.youtube.com/playlist?lis...
Lecture 1: Signals and data acquisition
Focusing on hardware, digital/analog I/O, synchronization
🧵
Please like and repost to help us get the word out!
www.youtube.com/playlist?lis...
Lecture 1: Signals and data acquisition
Focusing on hardware, digital/analog I/O, synchronization
🧵
Reposted
Latest from our group in collaboration with Lotte Bjerre Knudsen and other Novo scientists. They developed a GLP-1/Leptin co-agonist that we put through its paces in a number of mouse models to prove that both parts of the molecule matter. More options on the table!
www.science.org/doi/10.1126/...
www.science.org/doi/10.1126/...
Glp1r-Lepr coexpressing neurons modulate the suppression of food intake and body weight by a GLP-1/leptin dual agonist
Orthogonal murine models demonstrate the bioactivity and neuronal targets of a GLP-1/leptin coagonist in relation to food intake and body weight.
www.science.org
December 4, 2024 at 8:27 PM
Latest from our group in collaboration with Lotte Bjerre Knudsen and other Novo scientists. They developed a GLP-1/Leptin co-agonist that we put through its paces in a number of mouse models to prove that both parts of the molecule matter. More options on the table!
www.science.org/doi/10.1126/...
www.science.org/doi/10.1126/...
Reposted
Everyone is talking about #Ozempic #Wegovy which are agonists of the GLP-1 receptor. For more about this receptor and its physiological role, see the quickguide by Michael Krashes in our latest issue
www.cell.com/current-biol...
www.cell.com/current-biol...
Glucagon-like peptide-1 receptor
Michael Krashes discusses glucagon-like peptide-1 receptors, their physiological role
in glucose metabolism and the mode of action of their agonists that are used to treat
obesity and were later shown...
www.cell.com
December 3, 2024 at 7:38 PM
Everyone is talking about #Ozempic #Wegovy which are agonists of the GLP-1 receptor. For more about this receptor and its physiological role, see the quickguide by Michael Krashes in our latest issue
www.cell.com/current-biol...
www.cell.com/current-biol...